The results of the analysis led by Dr. Lynn Adams, in the laboratory of Dr. Shiuan Chen, in the October 2011 problem of The Journal of Diet are published. Within their research, the group fed sets of mice specifically formulated diets containing 5 percent freeze-dried blueberry powder, 10 percent blueberry powder or a control diet plan including no blueberry powder. The human exact carbon copy of the 5 percent diet plan is approximately 2 cups of clean highbush blueberries each day. The difference between your two blueberry groups had not been significant. Additional confirmation of the outcomes was acquired when the experts conducted molecular research on tumor cells and found significant distinctions between your blueberry-fed and control groupings in gene patterns regarded as related to inflammatory illnesses and the proliferation and spread of cancers cells.Diffusion from the site of delivery in the mind has been a key problem plaguing the development of other neurotrophic factors for Parkinson's disease for some right time. We’ve further proof that MANF appears to have added biological advantages over various other neurotrophic factors in advancement, and the business intends to leverage these outcomes as we continue to progress our Parkinson's program, along with explore additional applications for MANF in orphan disease applications. The Company is currently evaluating various delivery systems to clinically deliver MANF to the brain in Parkinson's disease, and can update the marketplace of its intentions as definitive agreements emerge. Large pharmaceutical companies show significant curiosity in neurotrophic factors for Parkinson's disease for over two decades.